Background illustration for clinical trials search

Liver Cancer Clinical Trials

Browse 274 liver cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Study of Tremelimumab and Durvalumab (MEDI4736) (T300+D) in Advanced Hepatocellular Carcinomas With Child-Pugh-B Cirrhosis

for
Hepatocellular Carcinoma, Cirrhosis, Liver
Location: San Antonio TX
Sponsor: The University of Texas Health Science Center at San Antonio

Sex: All

Age: 18+

Code: NCT06526104

Phase2, Recruiting

Combination of TATE and PD-1 Inhibitor in Liver Cancer

for
Hepatocellular Carcinoma, Gastric Cancer
Location: Milwaukee WI, Oklahoma City OK, Orange CA
Sponsor: Teclison Ltd.

Sex: All

Age: 18 - 70+

Code: NCT03259867

Phase2, Recruiting

High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies

for
Liver Malignant Tumors, Cholangiocarcinoma Metastatic,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 19+

Code: NCT05053555

Recruiting

A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer

for
Hepatocellular Carcinoma, Cirrhosis
Location: Fairfax VA
Sponsor: Inova Health Care Services

Sex: All

Age: 18+

Code: NCT06007846

Phase2, Phase3, Recruiting

OAR-Based, Dose Escalated SBRT With Real Time Adaptive MRI Guidance for Liver Metastases

for
Liver Metastases, Stereotactic Body Radiation Therapy,
Location: Madison WI
Sponsor: University of Wisconsin, Madison

Sex: All

Age: 18+

Code: NCT04020276

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Tislelizumab Consolidation After Liver-Directed Therapy for Hepatocellular Carcinoma

for
Carcinoma, Hepatocellular, Liver Cell Carcinoma
Location: The Bronx NY, New Brunswick NJ
Sponsor: Rutgers, The State University of New Jersey

Sex: All

Age: 18+

Code: NCT05366829

Phase2, Recruiting

SBRT With Atezo/Bev for HCC

for
Hepatocellular Carcinoma
Location: Philadelphia PA
Sponsor: Abramson Cancer Center at Penn Medicine

Sex: All

Age: 18 - 70+

Code: NCT05488522

Phase1, Recruiting

First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours

for
Hepatocellular Carcinoma
Location: St Louis MO, Houston TX, Los Angeles CA
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06795022

Phase1, Phase2, Recruiting

Alpha Radiation Emitters Device (DaRT) for the Treatment of Liver Metastases

for
Liver Metastases
Location: Montreal
Sponsor: Alpha Tau Medical LTD.

Sex: All

Age: 18+

Code: NCT05829291

Recruiting

Neoadjuvant Dupilumab and Toripalimab in MSS CRC Subjects With Resectable Liver Metastases

for
Metastatic Colorectal Cancer, Liver Metastases
Location: New York NY
Sponsor: Dan Feng

Sex: All

Age: 18+

Code: NCT07277322

Phase1, Phase2, Recruiting

Zanzalintinib in Second Line and Beyond for the Treatment of Advanced Liver Cancer

for
Advanced Hepatocellular Carcinoma, Cirrhosis,
Location: Chicago IL
Sponsor: Devalingam Mahalingam

Sex: All

Age: 18+

Code: NCT07042919

Phase1, Phase2, Recruiting

Therasphere® and Systemic Therapy for Patients With Hepatocellular Carcinoma That is High-risk

for
Hepatocellular Carcinoma
Location: Chicago IL, Orland Park IL, Lake Forest IL,
Sponsor: Northwestern University

Sex: All

Age: 18+

Code: NCT05620771

Phase2, Recruiting

A Study of Standard Of Care Versus Radio Ablation in Early Stage HCC

for
Early Hepatocellular Carcinoma
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT07628751

Recruiting

Preoperative Ketogenic Diet for Reduction of Hepatic Steatosis

for
Liver Steatoses, Liver Metastasis Colon Cancer, NAFLD
Location: London
Sponsor: Anton Skaro

Sex: All

Age: 18+

Code: NCT05884723

Recruiting

A Trial Utilizing 18F-FS PG PET to Guide Therapy in Hepatocellular Carcinoma

for
Hepatocellular Carcinoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07116486

Phase1, Recruiting

Computer Guided Microwave Liver Ablation

for
Hepatocellular Carcinoma (HCC)
Location: Lebanon NH
Sponsor: NE Scientific INC

Sex: All

Age: 18 - 70+

Code: NCT07226869

Recruiting

A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)

for
Hepatocellular Carcinoma (HCC)
Location: Hackensack NJ, Nashville TN, Portland OR, Duarte CA
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07291076

Phase1, Phase2, Recruiting

Ultra-high Dose Radiation for Liver Metastasis Using MR-guided TReatment With Stereotactic Ablative Single-fraction

for
Liver Metastases
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT06362395

Phase3, Recruiting

Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma

for
Hepatocellular Carcinoma (HCC)
Location: Margate FL, Orange City FL, Houston TX, Tacoma WA,
Sponsor: Shanghai Henlius Biotech

Sex: All

Age: 18 - 65

Code: NCT07176650

Phase1, Recruiting

Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients

for
Refractory Solid Tumor, Hepatocellular Carcinoma,
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 0 - 30

Code: NCT05468359

Phase1, Phase2, Recruiting